Synopsys, Inc. (SNPS) Analysts See $0.65 EPS

August 10, 2018 - By Lisa Delgado

Synopsys, Inc. (NASDAQ:SNPS) LogoInvestors sentiment decreased to 0.75 in Q1 2018. Its down 0.31, from 1.06 in 2017Q4. It turned negative, as 26 investors sold Synopsys, Inc. shares while 195 reduced holdings. 47 funds opened positions while 118 raised stakes. 128.97 million shares or 0.99% less from 130.26 million shares in 2017Q4 were reported.
Aviva Pcl reported 0.04% in Synopsys, Inc. (NASDAQ:SNPS). Victory Inc reported 1.20 million shares. Utd Services Automobile Association stated it has 0.08% in Synopsys, Inc. (NASDAQ:SNPS). Hanson Mcclain Inc accumulated 3 shares. Sumitomo Mitsui Asset Mngmt Ltd stated it has 0.03% of its portfolio in Synopsys, Inc. (NASDAQ:SNPS). Bbva Compass Natl Bank holds 0.08% of its portfolio in Synopsys, Inc. (NASDAQ:SNPS) for 15,280 shares. State Of Wisconsin Investment Board has invested 0.04% in Synopsys, Inc. (NASDAQ:SNPS). Schwab Charles Investment Mgmt Inc owns 842,374 shares. Ls Invest Advsr Ltd Com stated it has 0.04% in Synopsys, Inc. (NASDAQ:SNPS). 2,294 are held by Livforsakringsbolaget Skandia Omsesidigt. Hillsdale Invest holds 30 shares. Pettee Investors Inc stated it has 0.62% of its portfolio in Synopsys, Inc. (NASDAQ:SNPS). Ckw Gp holds 0.01% or 400 shares in its portfolio. Macquarie Group Inc Limited owns 1.80M shares or 0.27% of their US portfolio. Natixis holds 61,154 shares.

Since February 23, 2018, it had 0 insider buys, and 7 sales for $8.54 million activity. $873,410 worth of stock was sold by Logan Joseph W on Friday, February 23. The insider RUNKEL JOHN F JR sold $870,000.

Analysts expect Synopsys, Inc. (NASDAQ:SNPS) to report $0.65 EPS on August, 15.They anticipate $0.10 EPS change or 13.33 % from last quarter’s $0.75 EPS. SNPS’s profit would be $96.86M giving it 35.93 P/E if the $0.65 EPS is correct. After having $0.67 EPS previously, Synopsys, Inc.’s analysts see -2.99 % EPS growth. The stock increased 0.58% or $0.54 during the last trading session, reaching $93.42. About 870,253 shares traded. Synopsys, Inc. (NASDAQ:SNPS) has risen 20.11% since August 10, 2017 and is uptrending. It has outperformed by 7.54% the S&P500.

Synopsys, Inc. (NASDAQ:SNPS) Ratings Coverage

Among 2 analysts covering Synopsys (NASDAQ:SNPS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Synopsys has $112 highest and $102 lowest target. $107’s average target is 14.54% above currents $93.42 stock price. Synopsys had 3 analyst reports since February 22, 2018 according to SRatingsIntel. The rating was maintained by KeyBanc Capital Markets on Thursday, May 24 with “Overweight”. The firm has “Outperform” rating given on Thursday, May 24 by Credit Suisse. KeyBanc Capital Markets maintained it with “Overweight” rating and $110 target in Thursday, February 22 report.

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits (ICs). The company has market cap of $13.92 billion. It offers Galaxy Design platform that offers IC design solutions; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA) prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It has a 151.17 P/E ratio. The firm also offers DesignWare intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating point components, and ARM AMBA interconnect fabric and peripherals.

More news for Synopsys, Inc. (NASDAQ:SNPS) were recently published by: Nasdaq.com, which released: “Forget Bitcoin: You’re Better Off Buying These 3 Stocks” on August 06, 2018. Nasdaq.com‘s article titled: “Recent Analysis Shows Synopsys, Rigel Pharmaceuticals, Fate Therapeutics, Philip Morris International, Sally Beauty …” and published on July 27, 2018 is yet another important article.

Synopsys, Inc. (NASDAQ:SNPS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.